2018
DOI: 10.12968/bjhc.2018.24.3.156
|View full text |Cite
|
Sign up to set email alerts
|

How blockchain technology can improve the outcomes of clinical trials

Abstract: This article applies ‘outcome-driven innovation’ methodology, developed by Anthony Ulwick and popularised by Clayton Christensen, to the domain of clinical trials. Data were collected through in-depth, open interviews with doctors, nurses and researchers in the UK, France and Italy. Pain points for key players of the value chain were identified. The findings supported a multi-stakeholder approach to fully exploit the transformative potential of blockchain technology to resolve issues. The research identified a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(5 citation statements)
references
References 7 publications
0
4
0
Order By: Relevance
“…Some applications are proposed to consolidate patient data for hospital and physician use (OmniPHR by Ekblaw et al 2016), and others are offered as a single source for secure, fast, and transparent access (Medicalchain 2017). Borioli and Couturier (2018) discussed the potential of blockchain to conduct clinical trials using smart contracts, and Mamoshina et al (2018) proposed a roadmap for decentralizing the personal health data ecosystem for drug discovery, biomarker development, and preventative healthcare. MeDShare provides data provenance, auditing, and control of shared medical data in cloud repositories and monitors any malicious use of the data (Xia et al 2017).…”
Section: Prior Research On Blockchain Technology As a Platform For Re...mentioning
confidence: 99%
“…Some applications are proposed to consolidate patient data for hospital and physician use (OmniPHR by Ekblaw et al 2016), and others are offered as a single source for secure, fast, and transparent access (Medicalchain 2017). Borioli and Couturier (2018) discussed the potential of blockchain to conduct clinical trials using smart contracts, and Mamoshina et al (2018) proposed a roadmap for decentralizing the personal health data ecosystem for drug discovery, biomarker development, and preventative healthcare. MeDShare provides data provenance, auditing, and control of shared medical data in cloud repositories and monitors any malicious use of the data (Xia et al 2017).…”
Section: Prior Research On Blockchain Technology As a Platform For Re...mentioning
confidence: 99%
“…It can be seen that the CRO plays a vital role in CTs as the clinical study closeout report is generated and verified by them and later send to the sponsor for reporting it to the FDA and IRB. Table 1 summarizes the roles and key responsibilities of these stakeholders [28,29]. The current CT system is centralized around the sponsor and the process is monitored and controlled by the CRO.…”
Section: Figure 2: Different Phases In Ctsmentioning
confidence: 99%
“…MediBchain is another patient centric healthcare data management system that enables patient data sharing using cryptographic techniques [51]. Borioli and Couturier [52] discuss the potential of blockchain to conduct clinical trials using smart contracts, and Mamoshina et al [53] propose a roadmap for decentralizing the personal health data ecosystem for drug discovery, biomarker development, and preventative healthcare. The use of microscopy sensors that take an image of fingernails for identity authentication was proposed by Lee at al.…”
Section: Blockchain In Healthcarementioning
confidence: 99%